Literature DB >> 12845969

Use of the preoperative levels of CEA in patients with colorectal cancer.

J Marchena1, M A Acosta, F Garcia-Anguiano, H Simpson, F Cruz.   

Abstract

BACKGROUND/AIMS: Preoperative carcinoembryonic antigen has been considered useful as a prognostic factor and recurrence indicator of colorectal neoplasms. However, its diagnostic ability related to some parameters such as resectability or tumor staging has been less studied. The aim of this study was to evaluate the use of this marker as a diagnostic test for these parameters of colorectal cancer.
METHODOLOGY: In a sample of 283 patients operated on for colorectal carcinoma data were retrospectively recorded corresponding to preoperative carcinoembryonic antigen, type of surgery performed (curative vs. non-curative), tumor intramural spread, lymph node involvement, distant metastasis, TNM stage, tumoral differentiation, survival time and survival time free of disease. Bivariate analysis between carcinoembryonic antigen and the rest of the parameters was performed. Also, the sensitivity, specificity, positive predictive value, negative predictive value and diagnostic accuracy (efficiency) of the marker considered as a diagnostic test, were analyzed in relation to the tumoral resectability and tumoral spread.
RESULTS: Preoperative level of serum carcinoembryonic antigen was statistically significantly associated with type of surgery performed (p < 0.001); tumoral intramural spread (p = 0.001); lymph node involvement (p < 0.001); presence of distant metastasis (p < 0.001); TNM staging (p < 0.001); overall survival period (p < 0.001) and disease-free survival time (p = 0.04). There was no relation between carcinoembryonic antigen and the degree of tumoral differentiation. The carcinoembryonic antigen's greatest sensitivity corresponded with the prediction for the type of the surgery performed and with the existence of distant metastasis, 80% and 70.9%, respectively. The negative predictive value was also high (> 90% in both cases). When considering the intramural spread, the specificity was 82% and its positive predictive value 93.1%.
CONCLUSIONS: Preoperative levels of serum carcinoembryonic antigen, considered as a diagnostic test, are useful as predictors of resectability and tumor spread in colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845969

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  A carcinoembryonic antigen-secreting adenocarcinoma arising in tailgut cyst: clinical implications of carcinoembryonic antigen.

Authors:  Byoung Chul Cho; Nam Kyu Kim; Beom Jin Lim; Sang Ook Kang; Ju Hyuk Sohn; Jae Kyung Roh; Sang Tae Choi; Sung Ai Kim; Se Eun Park
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

2.  Hyperfibrinogenemia after preoperative chemoradiotherapy predicts poor response and poor prognosis in rectal cancer.

Authors:  Kazushige Kawai; Joji Kitayama; Nelson H Tsuno; Eiji Sunami; Hirokazu Nagawa
Journal:  Int J Colorectal Dis       Date:  2010-09-01       Impact factor: 2.571

3.  Can biliary carcinoembryonic antigen identify colorectal cancer patients with occult hepatic metastases?

Authors:  Giovanni Li Destri; Raffaele Lanteri; Marco Santangelo; Benedetto Torrisi; Antonio Di Cataldo; Stefano Puleo
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

4.  A simple scoring system based on clinical features to predict locally advanced rectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Xiaoli Zhu; Junjie Peng; Zuofeng Li; Changchun Xiao; Xiang Du; Ji Zhu; Peng Lian; Weiqi Sheng; Zuqing Guan; Sanjun Cai
Journal:  J Gastrointest Surg       Date:  2009-04-15       Impact factor: 3.452

5.  Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers.

Authors:  Ai-Sheng Ho; Chien-Hsin Chen; Chun-Chia Cheng; Chia-Chi Wang; Hua-Ching Lin; Tsai-Yueh Luo; Gi-Shih Lien; Jungshan Chang
Journal:  Oncotarget       Date:  2014-01-30

6.  Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

Authors:  Ali Ilker Filiz; Ilker Sucullu; Yavuz Kurt; Dursun Ozgur Karakas; Bulent Gulec; Mehmet Levhi Akin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

7.  Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma.

Authors:  Jan Friederichs; Ralf Gertler; Robert Rosenberg; Michael Dahm; Hjalmar Nekarda; Bernhard Holzmann; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.